Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-03-08 5:43 pm |
N/A N/A |
AdaptHealth Corp. | AHCO | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. DEERFIELD PARTNERS L.P. Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. *Possible Member of 10% Group 10% Owner |
0 | $0 | 27,654,923 (Indirect) |
View |
Ownership |
2022-11-10 7:48 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Flynn James E Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Director by deputization Director 10% Owner |
0 | $0 | 11,077,928 (Indirect) |
View |
2021-11-12 Conversion |
2021-11-16 9:34 pm |
N/A N/A |
Oncology Institute Inc. | DFPH | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Possible Members of 10% Group 10% Owner |
85,153 | $0 | 7,972,273 (Indirect) |
View |
2021-11-12 Other |
2021-11-16 9:34 pm |
N/A N/A |
Oncology Institute Inc. | DFPH | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Possible Members of 10% Group 10% Owner |
5,150,390 | $0 | 7,972,273 (Indirect) |
View |
2021-08-02 Conversion |
2021-08-04 6:05 pm |
N/A N/A |
Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt HIF L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Director by Deputization Director 10% Owner |
141,346,947 | $0 | 45,964,999 (Indirect) |
View |
Ownership |
2021-07-28 6:58 pm |
N/A N/A |
Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt HIF L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Director by Deputization Director 10% Owner |
0 | $0 | 24,176,278 (Indirect) |
View |
2021-06-01 Conversion |
2021-06-03 5:04 pm |
N/A N/A |
Singular Genomics Systems Inc. | OMIC | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. *Possible Member of 10% Group 10% Owner |
26,457,723 | $0 | 1,657,148 (Indirect) |
View |
2021-06-01 Conversion |
2021-06-03 5:04 pm |
N/A N/A |
Singular Genomics Systems Inc. | OMIC | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. *Possible Member of 10% Group 10% Owner |
577,148 | $17.6 | 1,657,148 (Indirect) |
View |
Ownership |
2021-05-26 9:24 pm |
N/A N/A |
Singular Genomics Systems Inc. | OMIC | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. *Possible Member of 10% Group 10% Owner |
0 | $0 | 7,642,019 (Indirect) |
View |
2021-03-30 Conversion |
2021-03-30 3:42 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Possible Member of 10% Group 10% Owner |
3,308,137 | $0 | 3,933,137 (Indirect) |
View |
Ownership |
2021-03-25 6:27 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Possible Member of 10% Group 10% Owner |
0 | $0 | 3,308,137 (Indirect) |
View |
2020-07-28 Conversion |
2020-07-28 12:54 pm |
N/A N/A |
Annexon Inc. | ANNX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner |
8,544,977 | $0 | 808,914 (Indirect) |
View |
Ownership |
2020-07-23 7:08 pm |
N/A N/A |
Annexon Inc. | ANNX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner |
0 | $0 | 917,828 (Indirect) |
View |
2020-07-14 Conversion |
2020-07-14 11:39 am |
N/A N/A |
Nkarta Inc. | NKTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner |
5,963,470 | $0 | 1,209,936 (Indirect) |
View |
Ownership |
2020-07-09 6:56 pm |
N/A N/A |
Nkarta Inc. | NKTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner |
0 | $0 | 1,419,872 (Indirect) |
View |
Ownership |
2020-06-08 6:03 pm |
N/A N/A |
Larimar Therapeutics Inc. | LRMR | Flynn James E Deerfield Mgmt III L.P. Deerfield Mgmt IV L.P. Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund III L.P. Deerfield Private Design Fund IV L.P. Deerfield Healthcare Innovations Fund L.P. Director by Deputization Director 10% Owner |
0 | $0 | 6,091,250 (Indirect) |
View |